Suchergebnisse - "Alami, Abdallah"

PubPharm (12)

1

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination : Insights from a Pharmacovigilance Perspective

enthalten in: Journal of clinical medicine | 2023

von Alami, A. | Villeneuve, P. | Farrell, P. | +8

2

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations : a systematic review and meta-analysis

enthalten in: BMJ open | 2023

von Alami, A. | Krewski, D. | Farhat, N. | +8

3

Interventions for COVID-19 Vaccine Hesitancy : A Systematic Review and Narrative Synthesis

enthalten in: International journal of environmental research and public health | 2023

von Terrell, R. | Alami, A. | Krewski, D.

4

Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

enthalten in: Expert opinion on drug safety | 2023

von Otero-Losada, M. | Petrovsky, N. | Alami, A. | +6

5

Safety and effectiveness of NMDA receptor antagonists for depression : A multidisciplinary review

enthalten in: Pharmacotherapy | 2022

von Moore, T. | Alami, A. | Alexander, G. | +1

6

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations

enthalten in: Vaccines | 2022

von Alami, A. | Krewski, D. | Mattison, D. | +6

7

Systemic quinolones and risk of retinal detachment I : analysis of data from the US FDA adverse event reporting system

enthalten in: Expert opinion on drug safety | 2022

von Taher, M. | Alami, A. | Gravel, C. | +5

8

Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system

enthalten in: Expert opinion on drug safety | 2022

von Taher, M. | Alami, A. | Gravel, C. | +5

9

Safety and effectiveness of NMDA receptor antagonists for depression : A multidisciplinary review

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2022

von Moore, T. | Alami, A. | Alexander, G. | +1

10

Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

enthalten in: bioRxiv.org | 2021

von Perez-Lloret, S. | Petrovsky, N. | Alami, A. | +5